Skip to main content

Deloitte’s $20m prize to cure cancer will supercharge science

By October 14, 2016News
laboratory-blood-work-biotech-pixa

laboratory-blood-work-biotech-pixa

Historically prizes have been surprisingly effective at kickstarting innovation, will Deloitte’s XPRIZE do the same?

Curing cancer is the holy grail of the medical and scientific communities, but a simple prize could make a whole lot of difference.

{iframe}http://www.thememo.com/2016/10/11/why-deloittes-20m-prize-to-cure-cancer-is-about-to-supercharge-science/{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.